AstraZeneca (NYSE: AZN) and Rigel Pharmaceuticals Inc. (Nasdaq: RIGL) today announced an exclusive worldwide license agreement for the global development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE